Nexvet Biopharma plc (NASDAQ:NVET) Reported Basic Consolidated EPS Of $-1.6814 For Period Ended 2016-06-30

0

The annual basic consolidated EPS for Nexvet Biopharma plc (NASDAQ:NVET) for the period ended 2016-06-30 was $-1.6814. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2016-06-30 was $-1.6814.

EPS from continuing operations

Coming to basic EPS from continuing operations, Nexvet Biopharma plc (NASDAQ:NVET) reported $-1.6814 for the annual period ended 2016-06-30. Quarterly basic EPS from continuing operations for the three-month period ended 2016-06-30 stood at $-1.6814.

EPS contribution from parent

For the annual period ended 2016-06-30, Nexvet Biopharma plc (NASDAQ:NVET) received basic EPS of $-1.6814 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2016-06-30 was $-1.6814.

Basic net EPS

For the annual period ended 2016-06-30, Nexvet Biopharma plc (NASDAQ:NVET) reported basic net EPS of $-1.68. On quarterly basis, the company’s basic net EPS for the three-month period ended 2016-06-30 stood at $-1.68.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2016-06-30 stood at $-1.6814. For the quarter ended 2016-06-30, consolidated diluted EPS was $-1.6814.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-1.6814 for the period ended 2016-06-30. Diluted EPS from continuing operations for the quarter ended 2016-06-30 was $-1.6814.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2016-06-30 was $-1.68. For the quarterly period ended 2016-06-30, net diluted EPS was $-1.68.

Diluted EPS from parent

From the parent company, Nexvet Biopharma plc (NASDAQ:NVET) received diluted EPS of $-1.6814 for the annual period ended 2016-06-30. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2016-06-30 was $-1.6814.

Nexvet Biopharma plc (NASDAQ:NVET) posted net basic EPS reading of $-1.68 for the annual period ended 2016-06-30. For the quarter, basic net EPS of $-1.68 was for the quarter ended 2016-06-30.

Net diluted EPS for Nexvet Biopharma plc (NASDAQ:NVET) for the annual period ended 2016-06-30 was $-1.68. The company also reported net diluted EPS reading of $-1.68 for the quarter ended 2016-06-30.

The annual average basic shares outstanding for the period ended 2016-06-30 is 11.518 while for the quarter ended 2016-06-30 is 11.518.

The diluted shares outstanding for the fiscal year ended is 2016-06-30 is 11.518 while for the quarter ended 2016-06-30 is 11.518.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 13 times, 1 visits today)